IL6 and IgA glomerulonephritis: The n-3 PUFA (DHA+EPA) concentration used here, 35.4 g/kg, was selected because this approximate level has been previously demonstrated to be efficacious by our laboratory for ameliorating both deoxynivalenol-induced IgA nephropathy and ex vivo IL-6 expression [43], [109], [110].